Journal of Clinical Oncology, Vol 24, No 32 (November 10), 2006: pp. 5160-5165
© 2006 American Society of Clinical Oncology.
DOI: 10.1200/JCO.2006.07.3114
Pediatric Cancer Survivorship: Research and Clinical Care
Anna T. Meadows
From the Children's Hospital of Philadelphia, Philadelphia, PA
Address reprint requests to Anna T. Meadows, MD, The Children's Hospital of Philadelphia, 34th St and Civic Center Blvd, Philadelphia, PA 19104-4399; e-mail: meadows{at}email.chop.edu
Regardless of how one defines survivorship, more than 10 million individuals in the United States have been treated for a malignant disease; about 250,000 were younger than 21 years of age at diagnosis. Thirty years ago, pediatric oncologists recognized that children with cancer might be cured by adding chemotherapy to surgery and radiation. Studies were then begun of complications that could reduce survival or the quality of survival, and that might be associated with previous therapy. The complications were termed late effects, and studies focused on patients who were likely to be cured, or less likely to succumb to the original cancer than they were to experience disabilities. Clinical trials tested whether changes in therapy to reduce complications could maintain the same excellent survival rates. During the last 20 years, articles detailing late effects and the relationship between therapy and outcome have been published. This article reviews the progress made in understanding the outcomes reported and the efforts made to improve the quality of long-term survival for children and adolescents. Several questions remain regarding the long-term complications of therapy. Clinicians need more data regarding the effects of aging to guide them in managing former patients. Caregivers and pediatric cancer survivors who are now adults seek the optimal venue in which to receive care as independent adults. In addition, medical oncologists need to determine whether the models for research and clinical care of survivors created in pediatric oncology can be applied to survivors of adult-onset cancer.
Author's disclosures of potential conflicts of interest and author contributions are found at the end of this article.
 CiteULike  Complore  Connotea  Del.icio.us  Digg  Facebook  Reddit  Technorati  Twitter What's this?
This article has been cited by other articles:
|
|
|
|
 
L. A. Jacobs, S. C. Palmer, L. A. Schwartz, A. DeMichele, J. J. Mao, J. Carver, C. Gracia, C. E. Hill-Kayser, J. M. Metz, M. K. Hampshire, et al.
Adult Cancer Survivorship: Evolution, Research, and Planning Care
CA Cancer J Clin,
November 1, 2009;
59(6):
391 - 410.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
K. Ruccione
The Legacy of Pediatric Oncology Nursing in Advancing Survivorship Research and Clinical Care
Journal of Pediatric Oncology Nursing,
September 1, 2009;
26(5):
255 - 265.
[Abstract]
[PDF]
|
|
|
|
|
|
|
J. W. Han, S. Y. Kwon, S. C. Won, Y. J. Shin, J. H. Ko, and C. J. Lyu
Comprehensive clinical follow-up of late effects in childhood cancer survivors shows the need for early and well-timed intervention
Ann. Onc.,
July 1, 2009;
20(7):
1170 - 1177.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
S. Lie Fong, J.S.E. Laven, F.G.A.J. Hakvoort-Cammel, I. Schipper, J.A. Visser, A.P.N. Themmen, F.H. de Jong, and M.M. van den Heuvel-Eibrink
Assessment of ovarian reserve in adult childhood cancer survivors using anti-Mullerian hormone
Hum. Reprod.,
April 1, 2009;
24(4):
982 - 990.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
M. E. Hewitt, A. Bamundo, R. Day, and C. Harvey
Perspectives on Post-Treatment Cancer Care: Qualitative Research With Survivors, Nurses, and Physicians
J. Clin. Oncol.,
June 1, 2007;
25(16):
2270 - 2273.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
J. H. Rowland, M. Hewitt, and P. A. Ganz
Cancer Survivorship: A New Challenge in Delivering Quality Cancer Care
J. Clin. Oncol.,
November 10, 2006;
24(32):
5101 - 5104.
[Full Text]
[PDF]
|
|
|
|
